INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

NEW YORK, Feb. 23, 2016

To: All persons or entities who purchased or otherwise acquired securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between May 17, 2013 and December 28, 2015.

You are hereby notified that a class action lawsuit has been commenced in the USDC for the Southern District of New York. If you purchased or otherwise acquired Anavex between May 17, 2013 and December 28, 2015, your rights may be affected by this action. To get more information go to:

http://zlk.9nl.com/anavex

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

According to the complaint, Anavex issued misleading statements and failed to disclose that the Company had used a paid stock promoter to artificially inflate the Company's share price.

On December 29, 2015, Anavex disclosed that it had received a subpoena from the SEC on December 22, 2015.  Anavex stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."  Then on December 30, 2015, Seeking Alpha published a report entitled "Anavex: A Regulatory Target Damaged By Incriminating Evidence."  On this news, Anavex stock fell $0.78, or 12.42%, to close at $5.50 per share.